Point72 Asset Management
ENTX icon

Point72 Asset Management’s Entera Bio ENTX Stock Holding History

Point72 Asset Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7K Sell
12,382
-1,181,271
-99% -$1.66M ﹤0.01% 3693
2025
Q4 		$2.32M Buy
1,193,653
+15,210
+1% +$35.7K ﹤0.01% 2379
2025
Q3 		$2.26M Sell
1,178,443
-1,518,793
-56% -$2.91M ﹤0.01% 1389
2025
Q2 		$5.12M Hold
2,697,236
– – 0.01% 962
2025
Q1 		$4.59M Buy
+2,697,236
New +$5.87M 0.01% 956

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Point72 Asset Management's ENTX Position: Q1 2026 in Review

Point72 Asset Management reduced its Entera Bio (ENTX) stake by 99% in Q1 2026, selling an estimated $1.66M and leaving 12,382 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3693.

Point72 Asset Management first reported a position in ENTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.12M in Q2 2025. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • Point72 Asset Management held 12,382 shares of Entera Bio worth $13.7K as of Q1 2026.
  • Point72 Asset Management sold 1,181,271 Entera Bio shares in Q1 2026, an estimated $1.66M.
  • Entera Bio made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3693 holding.
  • Point72 Asset Management first reported a position in Entera Bio in Q1 2025 and has held it in 5 quarters since.
  • Point72 Asset Management's Entera Bio position peaked at $5.12M in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.